Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 50,932,592
  • Shares Outstanding, K 383,240
  • Annual Sales, $ 6,848 M
  • Annual Income, $ -4,714 M
  • 60-Month Beta 1.57
  • Price/Sales 7.43
  • Price/Cash Flow N/A
  • Price/Book 3.97
Trade MRNA with:

Options Overview Details

View History
  • Implied Volatility 41.88% ( -4.71%)
  • Historical Volatility 51.28%
  • IV Percentile 2%
  • IV Rank 6.40%
  • IV High 67.77% on 10/27/23
  • IV Low 40.11% on 09/14/23
  • Put/Call Vol Ratio 0.53
  • Today's Volume 47,676
  • Volume Avg (30-Day) 38,675
  • Put/Call OI Ratio 1.06
  • Today's Open Interest 388,169
  • Open Int (30-Day) 322,615

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -3.45
  • Number of Estimates 12
  • High Estimate -3.09
  • Low Estimate -4.20
  • Prior Year -3.62
  • Growth Rate Est. (year over year) +4.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
99.30 +33.84%
on 04/22/24
134.60 -1.26%
on 05/17/24
+29.46 (+28.48%)
since 04/17/24
3-Month
85.53 +55.38%
on 02/21/24
134.60 -1.26%
on 05/17/24
+44.53 (+50.39%)
since 02/16/24
52-Week
62.55 +112.47%
on 11/02/23
142.79 -6.93%
on 05/24/23
+7.33 (+5.84%)
since 05/17/23

Most Recent Stories

More News
Could Novavax Become the Next Moderna?

Sanofi believes in Novavax's vaccine strengths...

SNY : 48.67 (-0.31%)
PFE : 28.64 (-0.97%)
NVAX : 13.01 (-9.65%)
MRNA : 132.90 (+0.17%)
Is This a Setback for Moderna?

Moderna's shares slipped after the company announced the delay.

PFE : 28.64 (-0.97%)
GSK.LN : 1,775.000 (-0.48%)
MRNA : 132.90 (+0.17%)
Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Patience often pays off in the equity markets.

MRNA : 132.90 (+0.17%)
DXCM : 131.36 (-0.42%)
Moderna to Present at Upcoming Conferences in May/June 2024

CAMBRIDGE, MA / ACCESSWIRE / May 13, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

MRNA : 132.90 (+0.17%)
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?

This team-up is more than a PR stunt, but it might not be revolutionary.

MRNA : 132.90 (+0.17%)
Stocks Shake off Mostly Negative News to Close Mildly Higher

The S&P 500 Index ($SPX ) (SPY ) Friday rose +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.26%. US stocks on Friday gained support...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
MU : 125.29 (-2.03%)
AMAT : 212.08 (-0.91%)
NVDA : 924.79 (-1.99%)
ASML : 924.97 (+0.59%)
MRVL : 71.92 (-1.59%)
Stocks See Support from Higher Chip Stocks and Earnings Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.06%. US stock indexes today are slightly...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
AMAT : 212.08 (-0.91%)
MU : 125.29 (-2.03%)
NVDA : 924.79 (-1.99%)
MRNA : 132.90 (+0.17%)
TSLA : 177.46 (+1.50%)
Moderna Announces Update on Investigational RSV Vaccine

U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024

MRNA : 132.90 (+0.17%)
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today

The COVID-19 pandemic thrust this company's science -- and its stock -- into the spotlight.

MRNA : 132.90 (+0.17%)
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024

EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END

MUSLF : 0.1852 (-3.69%)
MUSL.CN : 0.2550 (-1.92%)
MRK : 131.19 (+0.24%)
PFE : 28.64 (-0.97%)
MRNA : 132.90 (+0.17%)
AZN : 76.90 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 140.04
2nd Resistance Point 137.32
1st Resistance Point 135.11
Last Price 132.90
1st Support Level 130.18
2nd Support Level 127.46
3rd Support Level 125.25

See More

52-Week High 142.79
Last Price 132.90
Fibonacci 61.8% 112.14
Fibonacci 50% 102.67
Fibonacci 38.2% 93.20
52-Week Low 62.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar